← Dashboard
Aug 06, 2026 08:40 PM ET
Catalyst
FDA/Bio
MODERNA'S MRNA FLU SHOT EARNS FDA APPROVAL AFTER ROLLERCOASTER REVIEW - ARSTECHNICA
MODERNA'S MRNA FLU SHOT EARNS FDA APPROVAL AFTER ROLLERCOASTER REVIEW - ARSTECHNICA
What changed
Why it matters
Sources
arstechnica
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →